A "unifying theory" of chronic fatigue could reshape how we diagnose and treat five major illnesses

Five conditions long treated as unrelated — long Covid, ME/CFS, PTSD, rheumatoid arthritis, and multiple sclerosis — may all be disrupting the same core biological systems, according to a new study from the University of East Anglia and Oxford BioDynamics, published in the Journal of Translational Medicine. Despite being triggered by vastly different events (viral infection, trauma, autoimmune activity), all five conditions share a hallmark: debilitating, overlapping fatigue.

The key insight came not from standard genetic sequencing, but from analyzing the 3D architecture of the genome using Oxford BioDynamics' EpiSwitch® Orion platform. While individual gene overlap across the five conditions was surprisingly minimal, the networks those genes feed into — covering immune signaling, mitochondrial energy production, metabolic regulation, and stress-response pathways — showed striking convergence.

Key Takeaways:

• ME/CFS and long Covid currently lack universally accepted lab-based diagnostic tests; shared biological signatures could enable objective blood tests
• The gene LAG3, linked to "T-cell exhaustion," was flagged as a candidate for further investigation in ME/CFS
• Hub genes identified in shared networks could become targets for treatments applicable across multiple chronic conditions
• Further validation studies are needed before any clinical application

Why it matters: Millions of patients with these conditions face years of diagnostic uncertainty and limited treatment options. A unified biological framework could accelerate the development of cross-condition diagnostics and therapies, fundamentally changing how medicine approaches chronic fatigue.